FRANKLIN, Mass., Oct. 11, 2018 /PRNewswire/ — Arthrosurface®, Inc. announced today the official launch of its latest product,the stemless OVOMotion™ Shoulder Arthroplasty System with Inlay Glenoid. FDA Cleared in April 2018, this stemless total shoulder system provides the surgeon with an approach that results in increased exposure to the glenoid, minimal bone removal, and is designed for patients with painful and/or severely disabled shoulder joints resulting from arthritis, traumatic events or AVN.

Link: https://www.arthrosurface.com/product-clinical/ovomotion-launch/